GlaxoSmithKline PLC Stock Forecast - Period Momentum Indicator
| GSK Stock | USD 33.70 0.35 1.05% |
GlaxoSmithKline Stock Forecast is based on your current time horizon. Although GlaxoSmithKline PLC's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of GlaxoSmithKline PLC's systematic risk associated with finding meaningful patterns of GlaxoSmithKline PLC fundamentals over time.
GlaxoSmithKline |
| Check GlaxoSmithKline PLC Volatility | Backtest GlaxoSmithKline PLC | Information Ratio |
GlaxoSmithKline PLC Trading Date Momentum
| On November 22 2024 GlaxoSmithKline PLC ADR was traded for 33.70 at the closing time. Highest GlaxoSmithKline PLC's price during the trading hours was 33.70 and the lowest price during the day was 33.17 . There was no trading activity during the period 0.0. Lack of trading volume on the 22nd of November did not cause price change. The overall trading delta to current price is 0.89% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare GlaxoSmithKline PLC to competition |
Other Forecasting Options for GlaxoSmithKline PLC
For every potential investor in GlaxoSmithKline, whether a beginner or expert, GlaxoSmithKline PLC's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. GlaxoSmithKline Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in GlaxoSmithKline. Basic forecasting techniques help filter out the noise by identifying GlaxoSmithKline PLC's price trends.GlaxoSmithKline PLC Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GlaxoSmithKline PLC stock to make a market-neutral strategy. Peer analysis of GlaxoSmithKline PLC could also be used in its relative valuation, which is a method of valuing GlaxoSmithKline PLC by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
GlaxoSmithKline PLC ADR Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of GlaxoSmithKline PLC's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of GlaxoSmithKline PLC's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
GlaxoSmithKline PLC Market Strength Events
Market strength indicators help investors to evaluate how GlaxoSmithKline PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GlaxoSmithKline PLC shares will generate the highest return on investment. By undertsting and applying GlaxoSmithKline PLC stock market strength indicators, traders can identify GlaxoSmithKline PLC ADR entry and exit signals to maximize returns.
GlaxoSmithKline PLC Risk Indicators
The analysis of GlaxoSmithKline PLC's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in GlaxoSmithKline PLC's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting glaxosmithkline stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.12 | |||
| Standard Deviation | 1.53 | |||
| Variance | 2.34 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of GlaxoSmithKline PLC to cross-verify your projections. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.28) | Dividend Share 0.61 | Earnings Share 1.54 | Revenue Per Share 15.38 | Quarterly Revenue Growth (0.02) |
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.